(888) 552-6760 SCHEDULE AN APPOINTMENT

Robert R. Jenq,

M.D.

Hematologist-Oncologist

No Rating
Biography photo
Location
City of Hope Comprehensive Cancer Center - Duarte
1500 East Duarte Road
Duarte, CA 91010
Specialties
Hematologic Oncology
Education
Medical school:

Doctor of Medicine, Oregon Health and Science University, Portland, OR

Residency:

Internal Medicine - Duke University, Durham, NC

Academic Appointments
  • Professor, Department of Hematology & Hematopoietic Cell Transplantation
  • Director, Microbiome Program, Department of Hematology & Hematopoietic Cell Transplantation
About Me

Robert R. Jenq, M.D., is the director of the Microbiome Program and a clinical professor in the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope® Cancer Center Duarte. Dr. Jenq has more than 20 years’ experience in genomics, bone marrow and stem cell transplantation and conducting research that translates scientific advancements into real-world treatments for cancer patients. 

In his clinical practice, Dr. Jenq focuses on leukemia, lymphoma and other blood and bone marrow cancers, working closely with patients, their loved ones and their care teams to create treatment plans that are safe, effective and tailored to each person’s unique needs. 

Dr. Jenq received his medical degree from Oregon Health and Sciences University in Portland, then completed an internal medicine residency at Duke University in Durham, North Carolina. He went on to complete a clinical and research fellowship at Memorial Sloan Kettering Cancer Center in New York City. Before joining City of Hope, he was deputy chair of the Department of Genomic Medicine at MD Anderson’s Acute Cancer Care Center in Houston, Texas. 

As a researcher, Dr. Jenq has led and participated in numerous studies on blood and bone marrow transplantation and developed novel medical technologies. His work has explored important topics such as the role of the gut microbiome in graft-versus-host disease and neutropenic fever in patients undergoing hematopoietic stem cell transplants. He is currently engaged in collaborative research projects across the U.S., Canada, Germany and Japan.

Patient reviews
The patient ratings and comments on this page are obtained from an external Press Ganey® outpatient survey provided to all eligible City of Hope patients within one to two weeks of their treatment occurrence. Raw data from the answers to the survey questions about our physicians are calculated by Press Ganey into a one- to five- star rating. In the spirit of transparency, all patient comments are posted as written by the patient, whether they are positive or negative. We only exclude comments if they are deemed to be slanderous or libelous, contain profanity or vulgar language, or do not relate to the patient's experience with the doctor involved. As a result, the comments are the views and opinions of the patients surveyed and are not endorsed by, and may not necessarily reflect the opinion of, City of Hope.